Clinical Trial Update: A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical study is evaluating the safety and efficacy of ETX101 in infants and children with SCN1A-positive Dravet syndrome, and is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• ETX101

Snippet

Sponsor: Encoded Therapeutics | Conditions: Dravet Syndrome | Phase 1, Phase 2 | Status: RECRUITING